1Seto Y, Kimura A, Akai Y, et al. (2003) Distribution of the Lactobacillus acidophilus complex in human fecal specimens examined by restriction fragment length polymorphism of the 16S rRNA genes. Biosci Microflora 22, 75–83.
2Takahashi H, Fujita T, Suzuki Y, et al. (2006) Monitoring and survival of Lactobacillus gasseri SBT2055 in the human intestinal tract. Microbiol Immunol 50, 867–870.
3Fujiwara S, Seto Y, Kimura A, et al. (2001) Establishment of orally-administered Lactobacillus gasseri SBT2055SR in the gastrointestinal tract of humans and its influence on intestinal microflora and metabolism. J Appl Microbiol 90, 343–352.
4Imai E, Fukui K, Ohta N, et al. (2002) Effects of Lactobacillus gasseri SBT2055 on dextran sulfate sodium-induced ulcerative colitis model in rats. Biosci Microflora 21, 179–183.
5Kadooka Y, Tominari K, Sakai F, et al. (2012) Prevention of rotavirus-induced diarrhea by preferential secretion of IgA in breast milk via maternal administration of Lactobacillus gasseri SBT2055. J Pediatr Gastroenterol Nutr 55, 66–71.
6Sato M, Uzu K, Yoshida T, et al. (2008) Effects of milk fermented by Lactobacillus gasseri SBT2055 on adipocyte size in rats. Br J Nutr 99, 1013–1017.
7Kadooka Y, Ogawa A, Ikuyama K, et al. (2011) The probiotic Lactobacillus gasseri SBT2055 inhibits enlargement of visceral adipocytes and upregulation of serum soluble adhesion molecule (sICAM-1) in rats. Int Dairy J 21, 623–627.
8Kadooka Y, Sato M, Imaizumi K, et al. (2010) Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur J Clin Nutr 64, 636–643.
10Sanders ME (2003) Probiotics: considerations for human health. Nutr Rev 61, 91–99.
11Vasiljevic T & Shah NP (2008) Probiotics – from Metchnikoff to bioactives. Int Dairy J 18, 714–728.
12Sanders ME (2008) Probiotics: definition, sources, selection, and uses. Clin Infect Dis 46, S58–S61.
13Shigematsu R, Okura T, Kumagai S, et al. (2006) Cutoff and target values for intra-abdominal fat area for prevention of metabolic disorders in pre- and post-menopausal obese women before and after weight reduction. Circ J 70, 110–114.
14Garriguet D (2008) Impact of identifying plausible respondents on the under-reporting of energy intake in the Canadian Community Health Survey. Health Rep 19, 47–55.
15Murakami K, Sasaki S & Okubo H (2012) Characteristics of under- and over-reporters of energy intake among young Japanese women. J Nutr Sci Vitaminol (Tokyo) 58, 253–262.
16Buijs RM & Kreier F (2006) The metabolic syndrome: a brain disease? J Neuroendocrinol 18, 715–716.
17Kyrou I, Chrousos GP & Tsigos C (2006) Stress, visceral obesity, and metabolic complications. Ann N Y Acad Sci 1083, 77–110.
18Sniderman AD, Bhopal R, Prabhakaran D, et al. (2007) Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis. Int J Epidemiol 36, 220–225.
19Hao WL & Lee YK (2004) Microflora of the gastrointestinal tract: a review. Methods Mol Biol 268, 491–502.
20Gorbach SL (1996) Microbiology of the gastrointestinal tract. In Medical Microbiology, 4th ed., chapter 95 [Baron S, editor]. Galveston, TX: University of Texas Medical Branch at Galveston.
21Peach SL & Tabaqchali S (1984) Some studies of the bacterial flora associated with the mucosa of the human gastrointestinal tract. Nahrung 28, 627–634.
22Hoffmann M, Rath E, Holzlwimmer G, et al. (2008) Lactobacillus reuteri 100-23 transiently activates intestinal epithelial cells of mice that have a complex microbiota during early stages of colonization. J Nutr 138, 1684–1691.
23Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al. (2004) Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118, 229–241.
24Cario E (2008) Barrier-protective function of intestinal epithelial Toll-like receptor 2. Mucosal Immunol 1, S62–S66.
25Ey B, Eyking A, Gerken G, et al. (2009) TLR2 mediates gap junctional intercellular communication through connexin-43 in intestinal epithelial barrier injury. J Biol Chem 284, 22332–22343.
26Lee J, Mo JH, Shen C, et al. (2007) Toll-like receptor signaling in intestinal epithelial cells contributes to colonic homoeostasis. Curr Opin Gastroenterol 23, 27–31.
27Cario E, Gerken G & Podolsky DK (2007) Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 132, 1359–1374.
28Ding S, Chi MM, Scull BP, et al. (2010) High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One 5, e12191.
29Ding S & Lund PK (2011) Role of intestinal inflammation as an early event in obesity and insulin resistance. Curr Opin Clin Nutr Metab Care 14, 328–333.
30Cani PD, Amar J, Iglesias MA, et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761–1772.
31Tsukumo DM, Carvalho-Filho MA, Carvalheira JB, et al. (2007) Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 56, 1986–1998.
32Matsuki T, Watanabe K, Fujimoto J, et al. (2004) Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl Environ Microbiol 70, 7220–7228.
33Fleissner CK, Huebel N, Abd El-Bary MM, et al. (2010) Absence of intestinal microbiota does not protect mice from diet-induced obesity. Br J Nutr 104, 919–929.
34Conterno L, Fava F, Viola R, et al. (2011) Obesity and the gut microbiota: does up-regulating colonic fermentation protect against obesity and metabolic disease? Genes Nutr 6, 241–260.
35Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, et al. (2009) High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 137, 1716–1724.
36Queipo-Ortuno MI, Boto-Ordonez M, Murri M, et al. (2012) Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers. Am J Clin Nutr 95, 1323–1334.